Tasisulam 25 mg | 99.97%
TargetMol
Tasisulam is an apoptosis inducer and an antitumor agent via the intrinsic pathway.
More Information Supplier PageTasisulam
Search Results
Tasisulam 10 mg | 99.97%
TargetMol
Tasisulam is an apoptosis inducer and an antitumor agent via the intrinsic pathway.
More Information Supplier PageTasisulam
Mirdametinib 5 mg | 99.91%
TargetMol
PD0325901 is a specific and non-ATP-competitive MEK inhibitor (IC50: 0.33 nM).
More Information Supplier PageMirdametinib
Dalcetrapib 5 mg | 97.99%
TargetMol
Dalcetrapib, a rhCETP inhibitor (IC50=0.2 μM), increases the plasma HDL cholesterol.
More Information Supplier PageDalcetrapib
Dalcetrapib 10 mg | 97.99%
TargetMol
Dalcetrapib, a rhCETP inhibitor (IC50=0.2 μM), increases the plasma HDL cholesterol.
More Information Supplier PageDalcetrapib
Succinobucol 5 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
Succinobucol 50 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
Succinobucol 25 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
Succinobucol 10 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
VCMMAE 5 mg | 99.58%
TargetMol
VcMMAE is a drug-linker conjugate for ADC with potent antitumor activity.
More Information Supplier PageVCMMAE
